The detailed information for PTAB case with proceeding number IPR2020-00822 filed by Upjohn US 1 LLC et al. against Sun Pharmaceutical Industries Limited on Apr 9, 2020. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2020-00822
Filing Date
Apr 9, 2020
Petitioner
Upjohn US 1 LLC et al.
Respondent
Sun Pharmaceutical Industries Limited
Status
Terminated-Settled
Respondent Application Number
14374568
Respondent Tech Center
1600
Respondent Patent Number
9393205
Termination Date
Aug 26, 2020

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Termination Decision Document

Aug 26, 2020PAPERBOARD

Joint Motion to Terminate

Aug 25, 2020PAPERPETITIONER

Exhibit 1032 - Settlement & License Agmt

Aug 25, 2020EXHIBITPETITIONER

Mandatory Notices

Jul 31, 2020PAPERPATENT OWNER

Power of Attorney

Jul 31, 2020PAPERPATENT OWNER

Notice of Accord Filing Date

Apr 20, 2020PAPERBOARD

Exhibit 1001: U.S. Patent No. 9,393,205 to Kumar et al.

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1003: File History of U.S. Patent No. 9,393,205

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1006: Lyrica 2010 Prescribing Information

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1008: S.S. Davis, J. G. Hardy, & J. W. Fara, Transit of Pharmaceutical Dosage Forms Through the Small Intestine, 27 GUT 886 (1986)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1012: Orange Book Listing for Lyrica CR

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1014: Excerpt of Plaintiff's Disclosure of Asserted Claims and Infringement Contentions, dated September 13, 2019 (19-cv-9330, D.N.J.)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1015: Plaintiff and Counterclaim-Defendant's Response to Pfizer's Initial Invalidity Contentions, dated November 19, 2019 (19-cv-9330, D.N.J.)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1016: Lyrica CR Highlights of Prescribing Information

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1004: U.S. Patent Application Publication No. 2007/0269511

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1005: U.S. Patent Application Publication No. 2007/0184104

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1007: Garima Chawla et al., Gastroretention: A Means to Address Regional Variability in Intestinal Drug Absorption, PHARM. TECH. 50 (2003)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1009: R. Garg & G.D. Gupta, Progress in Controlled Gastroretentive Delivery Systems, 7 TROP. J. PHARM. RES. 1055 (2008)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1010: Haresh T. Mulani, Formulation and Evaluation of Kollidon SR for PH-Independent Extended Release Matrix Systems for Propanolol Hydrochloride, 3 J. PHARM. SCI. & RES. 5, 1233-44 (2011)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1011: Vivek K. Pawar et al., Gastroretentive Dosage Forms: A Review With Special Emphasis on Floating Drug Delivery, 18 DRUG DELIVERY 97 (2011)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1013: Webster's New College Dictionary 472 (3d ed. 2008)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1018: U.S. Patent No. 6,261,601

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1020: U.S. Patent No. 8,945,620

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1021: U.S. Patent No. 9,144,559

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1023: U.S. Patent Application No. 2011/0135723

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1024: U.S. Patent Application No. 2011/0294885

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1025: WO 2011/151,708

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1026: Curriculum Vitae of Leonard J. Chyall, Ph.D.

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1027: Joint Claim Construction and Prehearing Statement, Sun Pharm. Indus. Ltd. v. Pfizer Inc., Case No. 19-cv-9330, D.I. 47 (January 16, 2020 D.N.J.)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1028: Excerpts from the HANDBOOK OF PHARMACEUTICAL EXCIPIENTS (5th ed. 2006)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1017: U.S. Patent No. 6,120,803

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1019: U.S. Patent No. 8,012,496

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1022: U.S. Patent No. 10,022,447

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1030: Waivers of the Service of Summons, Sun Pharm. Indus. Ltd. v. Pfizer Inc., Case No. 19-cv-9330, D.I. 5, D.I. 6 (Apr. 10, 2019 D.N.J.)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1031: Answer, Affirmative Defenses, Counterclaims and Joinder in Response to Plaintiffs' Complaint for Declaratory Judgment, Sun Pharmaceutical Indus. Ltd. v. Pfizer Inc., No. 19-cv-09335, D.I. 10 (June 24, 2019 D.N.J.)

Apr 9, 2020EXHIBITPETITIONER

Exhibit 1029: Complaint, Sun Pharm. Indus. Ltd. v. Pfizer Inc., Case No. 19-cv-9330, D.I. 1 (Apr. 5, 2019 D.N.J.)

Apr 9, 2020EXHIBITPETITIONER

Power of Attorney

Apr 9, 2020PAPERPETITIONER

Petition

Apr 9, 2020PAPERPETITIONER

Exhibit 1002: L. Chyall Declaration

Apr 9, 2020EXHIBITPETITIONER